Home » Topics » BioWorld Science

BioWorld Science
RSS

At ACS national meeting, researchers share their successes

Aug. 22, 2018

Boehringer Ingelheim discovers new FFAR1 agonists

Aug. 22, 2018

Lixte partners with Moffitt for phase Ib/II study of LB-100 in low and intermediate-1 risk MDS

Aug. 22, 2018

GNE-616: a promising non-opioid drug candidate for the treatment of Nav1.7-mediated pain

Aug. 22, 2018

ProMIS Neurosciences reports positive results for PMN-310 in Alzheimer's disease

Aug. 22, 2018

Ichor announces utilization of TriGrid delivery system in a phase I/IIb study of GX-188E vaccine

Aug. 22, 2018

Amgen initiates first-in-human studies with AMG-424 and AMG-397

Aug. 22, 2018

Viela Bio initiates first-in-human study of VIB-9600

Aug. 22, 2018

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Aug. 22, 2018

One protein affects translation of multiple autism risk genes

Aug. 22, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...